Stockreport

InspireMD Schedules Second Quarter 2018 Earnings Conference Call

InspireMD Inc.  (NSPR) 
NASDAQ:AMEX Investor Relations: inspiremd.com/en/investors/investor-relations
PDF Tel Aviv, July 31, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused [Read more]